The GT Plus assay detects genotypes 1a, 1b, and 6 in a single reaction with probes targeting the core region
Although analytical challenges and detection limits vary considerably among studies, the available findings already raise concerns and underscore the need for in-depth toxicological and kinetic evaluation
Both are used off-label in clinical peptide therapy protocols
We have worked closely with the FDA to resolve their questions expeditiously and are pleased that the clinical hold on our DM1 program in the United States has been lifted, PepGen president and CEO James McArthur said in Thursdays press release
[DOI] [PMC free article] [PubMed] [Google Scholar] 130.akici N., van Beveren NJ M., Judge-Hundal G., Koola M.M., Sommer IE C
Research suggests that 1-2 cycles per year may provide optimal longevity benefits, though Dr